Biomedical Excellence for Safer Transfusion
  • Biomedical Excellence for Safer Transfusion (BEST)
    Biomedical Excellence for Safer Transfusion (BEST)

    BEST Collaborative is an international research organization with a vision to lead the field of transfusion medicine and cellular therapies toward the best…

  • BEST Membership
    BEST Membership

    The BEST collaborative is a unique free-standing group of over 170 manufacturers, clinicians, and scientists from 22 countries committed to improving transfusion…

  • BEST Meetings
    BEST Meetings

    BEST meetings are held twice per year. and attendance is open to all members. Invited guests may attend with pre-approval of the Chair.

  • Press Releases
    Press Releases

    Official notices regarding significant publications, special events, and member news.

  • Recommended Procedures
    Recommended Procedures

    Several best practice documents are available for download

  • Sponsorship

    Any commercial organization or Blood Service interested in advancing the purpose of BEST may become a supporter of BEST by paying the annual dues amount; providing a…

Latest News

Call for Scott Murphy Memorial Lecture Applications

Applications for April 2024 are being accepted now thru March 4, 2024

Press Release 21 Sept 2023

Rebecca Cardigan, PhD elected President, effective Oct 2023

Press Release 07 September 2023

Award Recipient of 31st Scott Murphy Memorial Award Lectureship Announced

BEST LXVII Amsterdam Meeting Countdown Friday, April 12, 2024 08:00 am CEST

Member News

  • Please be sure to keep your contact information on the website up to date so you can be assured of receiving our email updates.
  • The next BEST Meeting will be held in Nashville, TN October 10-11, 2023. Onsite registration will open shortly.
  • We will be also hold this meeting using the Zoom Events format with the same agenda and in Nashiville Time. Pre-registration is required using the individual email sent to each member and approved guest.
  • Please be sure to review the BEST Authorship Policy. BEST Members may find this information in the Members Area > References > Administrative Issues. This area is now searchable.

Spring 2024



The Spring 2024 Meeting is confirmed for Amsterdam, Netherlands

Important News

  • The meeting dates are set for April 12-13, 2024
  • The meeting venue is the DoubleTree by Hilton Amsterdam Centraal Station 
  • A room block is not being established, but a 10% discount will be available at the meeting venue. Details on this and the dinner venue will be available in August 2023.

Fall 2024



The Fall 2024 Meeting is planned for Galveston, TX

Important News

  • The meeting and dinner venues have been confirmed.
  • The AABB Annual Meeting is scheduled for October 19-22, 2204 in Houston. The BEST meeting will be held on October 16-17, 2024. Please note that many of our members have AABB Meetings that they must attend on October 18th.
  • We will announce the arrangement details as soon as they are available.

The Biomedical Excellence for Safer Transfusion (BEST) Collaborative is an international research organization with a vision to lead the field of transfusion medicine and cellular therapies toward the best products and practices for donors and patients. We currently operate in teams covering 4 areas: Conventional Blood Components, Clinical Transfusion Studies, Cellular Therapy, and Donor Studies.

We have 42 scientific members, 15 manufacturing sponsors, and 21 blood service sponsors from 21 countries representing a diversity of interests and high levels of accomplishment. The supporting members of BEST span a broad range of the companies and blood suppliers engaged with blood collection, distribution and transfusion worldwide. We also have been pleased to have some participation from regulatory agencies such as FDA and the Paul Ehrlich Institute. BEST has published 135 peer-reviewed papers and has 40 studies currently open. As part of our mission, BEST believes it brings to the community thoughtful consideration to identify important questions in Transfusion Medicine, design and execute studies to address these questions, and provide critical thought and synthesis of the available evidence.